Kairos Pharma (KAPA) Stock Chart & Stock Price History $0.65 -0.04 (-6.33%) As of 07/3/2025 05:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesOwnershipSEC FilingsBuy This Stock Kairos Pharma Stock Price Performance The Kairos Pharma (KAPA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 57.17%. In the past month, the stock has increased 25.05%, reflecting recent market activity. As of the latest close, Kairos Pharma traded at $0.65 with a market cap of $10.97 million and volume of 188,855 shares. Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.69%1 Month Performance+25.05%3 Month Performance-38.58%Year-To-Date Performance-57.17% KAPA Stock Chart for Friday, July, 4, 2025 KAPA Chart by TradingView Kairos Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$0.70$0.65-6.33%$0.69$0.65188,855 shs$10.97 million07/02/2025$0.70$0.70-0.71%$0.70$0.65700,842 shs$11.71 million07/01/2025$0.71$0.70-1.27%$0.71$0.64666,159 shs$11.80 million06/30/2025$0.67$0.71+5.98%$0.74$0.641.51 million shs$11.95 million06/27/2025$0.69$0.67-3.04%$0.71$0.65470,149 shs$11.27 million06/26/2025$0.63$0.69+9.35%$0.70$0.60835,413 shs$11.63 million06/25/2025$0.65$0.63-2.77%$0.68$0.62428,150 shs$10.63 million06/24/2025$0.64$0.65+1.41%$0.65$0.60481,034 shs$10.94 million06/23/2025$0.62$0.64+3.23%$0.69$0.61723,245 shs$10.78 million06/20/2025$0.61$0.62+1.64%$0.68$0.611.78 million shs$10.45 million Get the Latest News and Ratings for KAPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$0.61$0.61$0.62$0.55787,874 shs$10.28 million06/18/2025$0.57$0.61+6.11%$0.62$0.55787,874 shs$10.28 million06/17/2025$0.54$0.57+6.36%$0.63$0.521.31 million shs$7.88 million06/16/2025$0.52$0.54+3.94%$0.56$0.48747,345 shs$7.41 million06/13/2025$0.57$0.52-8.77%$0.54$0.50508,793 shs$7.12 million06/12/2025$0.49$0.57+16.16%$0.58$0.491.88 million shs$7.81 million06/11/2025$0.54$0.49-9.80%$0.52$0.49922,957 shs$6.72 million06/10/2025$0.57$0.54-3.99%$0.56$0.501.87 million shs$7.45 million06/09/2025$0.47$0.57+19.79%$0.57$0.469.72 million shs$7.76 million06/06/2025$0.50$0.47-5.87%$0.51$0.45814,080 shs$6.48 million06/05/2025$0.52$0.50-3.48%$0.53$0.451.87 million shs$6.88 million06/04/2025$0.45$0.52+15.69%$0.52$0.424.44 million shs$7.13 million06/03/2025$0.59$0.45-23.51%$0.53$0.4010.27 million shs$6.17 million Related Companies Werewolf Therapeutics Stock Chart Gain Therapeutics Stock Chart vTv Therapeutics Stock Chart Renovaro Stock Chart Century Therapeutics Stock Chart Atara Biotherapeutics Stock Chart RenovoRx Stock Chart Aadi Bioscience Stock Chart Precision BioSciences Stock Chart ZIVO Bioscience Stock Chart Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:KAPA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kairos Pharma, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kairos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
